scispace - formally typeset
W

Wiebke Hellenbrand

Researcher at Robert Koch Institute

Publications -  81
Citations -  2348

Wiebke Hellenbrand is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Vaccination & Tick-borne encephalitis. The author has an hindex of 25, co-authored 74 publications receiving 2078 citations. Previous affiliations of Wiebke Hellenbrand include Pasteur Institute.

Papers
More filters
Journal ArticleDOI

The seroepidemiology of herpes simplex virus type 1 and 2 in Europe

TL;DR: There is large variation in the seroepidemiology of herpes simplex virus types 1 and 2 in the general populations of eight European countries, particularly in northern Europe, and the observation that a significant proportion of adolescents are now HSV-1 susceptible may have implications for transmission and clinical presentation.
Journal ArticleDOI

A super-spreading ewe infects hundreds with Q fever at a farmers' market in Germany

TL;DR: It was recommended that pregnant sheep not be displayed in public during the 3rd trimester and to test animals in petting zoos regularly for C. burnetii as a consequence of this outbreak.
Journal ArticleDOI

Changing epidemiology of Q fever in Germany, 1947-1999.

TL;DR: The seasonality of community outbreaks has shifted from predominantly winter- spring to spring-summer, possibly because of changes in sheep husbandry, and the location of recent outbreaks suggests that urbanization of rural areas may be contributing to the increase in Q fever.
Journal ArticleDOI

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

TL;DR: During the 2009 influenza pandemic, a monovalent AS03-adjuvanted vaccine was almost exclusively used in Germany for immunisation against the 2009 pandemic influenza A(H1N1) virus.
Journal ArticleDOI

The epidemiology of pertussis in Germany: past and present

TL;DR: The shift in pertussis morbidity to older age groups observed in FEG is similar to reports from other countries with longstanding vaccination programs and suggests that additional booster vaccination may be necessary beyond adolescence.